| Literature DB >> 17600384 |
John Williams1, JodiAnne Wood, Lakshmipathi Pandarinathan, David A Karanian, Ben A Bahr, Paul Vouros, Alexandros Makriyannis.
Abstract
The endocannabinoid system's biological significance continues to grow as novel endocannabinoid metabolites are discovered. Accordingly, a myopic view of the system that focuses solely on one or two endocannabinoids, such as anandamide or 2-arachidonoyl glycerol, is insufficient to describe the biological responses to perturbations of the system. Rather, the endocannabinoid metabolome as a whole must be analyzed. The work described here is based on liquid chromatography coupled with atmospheric pressure chemical ionization mass spectrometry. This method has been validated to quantify, in a single chromatographic run, the levels of 15 known or suspected metabolites of the endocannabinoid system in the rat brain and is applicable to other biological matrixes. We have obtained an endocannabinoid profile specifically for the frontal cortex of the rat brain and have determined anandamide level differences following the administration of the fatty acid amide hydrolase inhibitor AM374.Entities:
Mesh:
Substances:
Year: 2007 PMID: 17600384 DOI: 10.1021/ac0624086
Source DB: PubMed Journal: Anal Chem ISSN: 0003-2700 Impact factor: 6.986